To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@mail.nih.gov along with the following information:

Your name, title, and organization
Study Number and Study Title
The specific dataset(s) you are requesting
The intended use or purpose of the data
Willingness to comply with the NIDA Datashare Registration Agreement

Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-CTO-0004

Division

DTMC

HEAL Study

Investigator(s)

Thomas F. Newton, M.D.

Title

Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline

Short Description

This is a human laboratory clinical pharmacology study to assess potential interactions between intravenous methamphetamine challenge and treatment with oral selegiline.

Release Date

Aug 01, 2016

Description

The primary objective of this study is to determine the safety of the selegiline concurrent with dmethamphetamine challenges of 15 mg and 30 mg i.v. The primary outcome measures are cardiovascular responses (HR, BP) to the i.v. methamphetamine challenges.

Keywords

Assessments

Beck Depression Inventory

Blood Methamphetamine Level

Blood Study Agent Level

Brief Symptom Inventory

ECG Monitoring